Researcher · Professor · Ph.D. Supervisor · Project Mentor

Duohong Zou

邹 多 宏

Executive Deputy Director, Department of Oral Surgery, Shanghai Ninth People's Hospital

Shanghai Health Discipline Leader · Shanghai Outstanding Young Medical Talent · Anhui Outstanding Young Talent · Fellow of the Royal College of Surgeons of England

30 SCI Papers 157 Authorized Patents 6 Technology Transfers 35 Marketed Medical Products

Biography

Clinical Leadership with Translational Implant Innovation

Professor Duohong Zou is a researcher, professor, Ph.D. supervisor and project mentor. He serves as the Executive Deputy Director of Oral Surgery at Shanghai Ninth People's Hospital and is recognized as a Shanghai Health Discipline Leader, Shanghai Outstanding Young Medical Talent and Anhui Outstanding Young Talent.

His long-term work focuses on severe jaw defect reconstruction and geriatric dental implantology. Guided by a stability-centered treatment philosophy, he helped establish a pure artificial bone substitute pathway for severe alveolar bone defects, reducing the need for autogenous bone harvesting.

His research directions cover severe alveolar bone defect reconstruction, oral implant fundamentals and medical-product translation, oral stem-cell clinical translation, and soft and hard tissue regeneration based on advanced biomaterials.

  1. Fellow of the Royal College of Surgeons of England.
  2. Lead investigator for six national-level projects, including one National Key R&D Program project.
  3. Selected into five provincial or bureau-level talent programs.
  4. Has led more than twenty research projects across clinical and translational pathways.

Clinical Expertise

Advanced Oral Surgery & Implant Translation

Clinical and translational work centered on severe jaw defects, aging patients and device-enabled implant care.

Surgical Innovation

Building a New System for Dental Implant Reconstruction

Framed around the clinical question of how to complete alveolar-bone repair and oral implantation more effectively, the team has developed four coordinated pathways covering reconstruction, personalized implant products, visualized navigation, and intelligent shade-matching.

Industrial Impact: 5 new treatment technologies, 157 authorized patents, 6 completed technology transfers, 3 Class III medical device certificates, 35 marketed medical products, and 7 clinical guidelines or expert-consensus documents led or co-drafted.

Honors & Recognition

National & Regional Medical Innovation Awards

Representative recognitions across medical-device translation, oral reconstruction research, and institutional leadership. The section is structured as a formal honors dossier rather than a card wall.